<?xml version="1.0" encoding="UTF-8"?>
<list list-type="order">
 <list-item>
  <p>Fecal viral shedding has been noted, yet the quantitative magnitude of viral load is much less than respiratory viral load, raising questions on whether it has the capacity to cause infection. Hence, the question of fecal transmission still remains open.</p>
 </list-item>
 <list-item>
  <p>Does infection lead to formation of protective antibodies? This is one question on which hangs the future of the world.</p>
 </list-item>
 <list-item>
  <p>Do patients with GI manifestations have a worse outcome?</p>
 </list-item>
 <list-item>
  <p>Do asymptomatic with fecal shedding require a prolonged quarantine period?</p>
 </list-item>
 <list-item>
  <p>Protean manifestations (neurological, myocarditis, diarrhea, acute hepatitis, hyperamylasemia) are emerging and many more will be added to the list.</p>
 </list-item>
 <list-item>
  <p>Are patients on immunomodulators and immunosuppressants more prone to viremia?</p>
 </list-item>
 <list-item>
  <p>Is it that only certain class of immunosuppressant (steroids, azathioprine) is more prone to infection with SARS-Cov2?</p>
 </list-item>
 <list-item>
  <p>Is colonoscopy a high-risk procedure and does every endoscopy require preprocedure testing for COVID?</p>
 </list-item>
 <list-item>
  <p> However, the baffling issues related to therapy: a constant see saw of evidence generated from observational or small sample-sized trials and the writing on the wall at present is (Recent IDSA statements) 
   <xref rid="OR_4" ref-type="bibr">4</xref> : 
  </p>
  <list list-type="simple">
   <list-item>
    <p>(i) Limited and heterogeneous clinical evidence on the efficacy of hydroxychloroquine in treatment of COVID-19.</p>
   </list-item>
   <list-item>
    <p> (ii) Among patients who have been admitted to the hospital with COVID-19, it recommends the use of any of these interventions 
     <italic>only in the setting of a clinical trial</italic> (hydroxychloroquine, combination of lopinavir/ritonavir, tocilizumab, COVID-19 convalescent plasma). 
    </p>
   </list-item>
   <list-item>
    <p>(iii) The bottom line: No therapy has been shown effective to date.</p>
   </list-item>
  </list>
 </list-item>
 <list-item>
  <p>Myriad social issues and the social stigma.</p>
 </list-item>
</list>
